ATE171871T1 - Fungizide zusammensetzungen enthaltend eine kombination von bifonazol und fluocinonid - Google Patents

Fungizide zusammensetzungen enthaltend eine kombination von bifonazol und fluocinonid

Info

Publication number
ATE171871T1
ATE171871T1 AT95301981T AT95301981T ATE171871T1 AT E171871 T1 ATE171871 T1 AT E171871T1 AT 95301981 T AT95301981 T AT 95301981T AT 95301981 T AT95301981 T AT 95301981T AT E171871 T1 ATE171871 T1 AT E171871T1
Authority
AT
Austria
Prior art keywords
bifonazole
fluocinonide
combination
compositions containing
fungicidal compositions
Prior art date
Application number
AT95301981T
Other languages
English (en)
Inventor
Marcel Zighelboim
Amnon Sintov
Original Assignee
Agis Ind 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Ind 1983 Ltd filed Critical Agis Ind 1983 Ltd
Application granted granted Critical
Publication of ATE171871T1 publication Critical patent/ATE171871T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AT95301981T 1994-04-05 1995-03-24 Fungizide zusammensetzungen enthaltend eine kombination von bifonazol und fluocinonid ATE171871T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10923094A IL109230A (en) 1994-04-05 1994-04-05 Anti-fungal composition containing bifonazole and fluocinonide

Publications (1)

Publication Number Publication Date
ATE171871T1 true ATE171871T1 (de) 1998-10-15

Family

ID=11065999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95301981T ATE171871T1 (de) 1994-04-05 1995-03-24 Fungizide zusammensetzungen enthaltend eine kombination von bifonazol und fluocinonid

Country Status (9)

Country Link
EP (1) EP0676198B1 (de)
JP (1) JPH0892097A (de)
CN (1) CN1075722C (de)
AT (1) ATE171871T1 (de)
DE (1) DE69505174T2 (de)
DK (1) DK0676198T3 (de)
ES (1) ES2123206T3 (de)
IL (1) IL109230A (de)
ZA (1) ZA951799B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618964D0 (en) * 1996-09-11 1996-10-23 Tillotts Pharma Ag Oral composition
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20060035983A1 (en) * 2002-08-20 2006-02-16 Pinnell Sheldon R Methods for treating fungal infections
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011024027A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of diflucortolone and terbinafine
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
CN104825388A (zh) * 2015-04-20 2015-08-12 陈亚春 一种联苯苄唑溶液及其制备方法
CN105287261B (zh) * 2015-10-28 2017-11-17 广州靓美莲美容科技有限公司 一种含玫瑰花油的杜鹃花酸复方祛痘膏及其制备方法
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
CN109432089A (zh) * 2018-11-02 2019-03-08 云南康创生物医药科技孵化有限公司 用于抗真菌的含联苯苄唑的药物组合物及其制备方法

Also Published As

Publication number Publication date
DE69505174D1 (de) 1998-11-12
DK0676198T3 (da) 1999-06-21
IL109230A (en) 1998-08-16
CN1111513A (zh) 1995-11-15
EP0676198A1 (de) 1995-10-11
JPH0892097A (ja) 1996-04-09
ZA951799B (en) 1996-01-25
ES2123206T3 (es) 1999-01-01
IL109230A0 (en) 1994-07-31
CN1075722C (zh) 2001-12-05
EP0676198B1 (de) 1998-10-07
DE69505174T2 (de) 1999-03-04

Similar Documents

Publication Publication Date Title
DE69505174D1 (de) Fungizide Zusammensetzungen enthaltend eine Kombination von Bifonazol und Fluocinonid
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
NO20004804L (no) Steroide sapogeninger samt deres derivater for behandling av Alzheimers sykdom
AU5217493A (en) Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
IL104915A0 (en) Pharmaceutical composition containing estrogen,progestin and antiprogestin and kits containing the same
FI971776A7 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
PT904098E (pt) Composicoes que incluem um agente antifungico e tampao acetato
FI883055A7 (fi) Deodoroiva ja antimikrobinen koostumus käytettäväksi kosmeettisissa tai paikallisesti käytettävissä valmisteissa.
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
FI924166A0 (fi) Vattenbaserad, loesningsmedel- och emulgatorfri mikrobicid kombination av aktiva aemnen.
DE69825579D1 (de) Zusammensetzung zur topischen anwendung auf die haut und deren koerperanhaengseln; die mindestens eine verbindung auf iminophenolbasis enthaelt
EE9800339A (et) Aminoisokinoliinid ja aminotienopüridiini derivaadid ning nende kasutamine põletikuvastaste ainetena
EP2348031A3 (de) 17-Alpha-substituiertes-11-Beta-substituiertes-4-aryl und 21-substituiertes 19-Norpregnadiendion als Antiprogestationswirkstoffe
HU9402932D0 (en) Angiotensin iin antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy
ATE181324T1 (de) Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen
ES2193765T3 (es) Pomada o crema de hiperforina.
DE69512715D1 (de) Aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
IT1274655B (it) Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
EP0603405A4 (de) Zusammensetzung zur behandlung der akne vulgarin.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
BG104258A (en) 4-cyano-4-deformylsordarin derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee